Laura C.A. Galbraith

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1K citations

Mcl1 Inhibitor S63845, Systems Biology, Oncology +11

Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells

Franziska Baenke, Barbara Chaneton, Matthew Smith et al. · Molecular Oncology · 2015 · 188 citations · Full text

<i>Sleeping Beauty</i>screen reveals<i>Pparg</i>activation in metastatic prostate cancer

Imran Ahmad, Ernest Mui, Laura C.A. Galbraith et al. · Proceedings of the National Academy of Sciences · 2016 · 119 citations · Full text

Bright insights into palladium-triggered local chemotherapy

Thomas L. Bray, Mark J. Salji, Alessandro Brombin et al. · Chemical Science · 2018 · 98 citations · Full text

Defining functional classes of Barth syndrome mutation in humans

Ya‐Wen Lu, Laura C.A. Galbraith, Jenny D. Herndon et al. · Human Molecular Genetics · 2016 · 72 citations · Full text

Mendelian Disorder, Mitochondrial Biogenesis, Mitochondrial Function +14